XNCR - Xencor Inc
IEX Last Trade
17.49
0.180 1.029%
Share volume: 355,456
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$17.31
0.18
1.04%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-03 | 2022-11-07 | 2023-02-27 | 2023-05-08 | 2023-08-03 | 2023-11-08 | 2024-02-29 | 2024-05-09 | |
| Assets | |||||||||
| Total Assets | 851.325 M | 835.269 M | 846.266 M | 803.411 M | 778.121 M | 778.430 M | 952.692 M | 884.255 M | |
| Current Assets | 585.936 M | 667.998 M | 675.342 M | 629.976 M | 593.562 M | 571.176 M | 623.160 M | 562.252 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 19.734 M | 22.886 M | 23.283 M | 22.093 M | 22.171 M | 21.644 M | 18.145 M | 16.736 M | |
| Short Term Investments | 19.734 M | 22.886 M | 23.283 M | 22.093 M | 22.171 M | 21.644 M | 18.145 M | 16.736 M | |
| Total Receivables | 54.284 M | 44.876 M | 28.997 M | 19.861 M | 20.019 M | 55.000 M | 11.290 M | 9.580 M | |
| Current Cash | 511.918 M | 600.236 M | 623.062 M | 588.022 M | 551.372 M | 494.532 M | 593.725 M | 535.936 M | |
| Total Non-current Assets | 265.389 M | 167.271 M | 170.924 M | 173.435 M | 184.559 M | 207.254 M | 329.532 M | 322.003 M | |
| Property Plant Equipment | 38.855 M | 51.040 M | 59.183 M | 66.685 M | 67.997 M | 68.035 M | 66.124 M | 63.540 M | |
| Other Assets | 5.613 M | 5.613 M | 613.000 K | 599.000 K | 598.000 K | 660.000 K | 1.028 M | 498.000 K | |
| Intangible Assets | 17.944 M | 18.094 M | 18.500 M | 18.244 M | 18.708 M | 18.744 M | 18.663 M | 18.852 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 851.325 M | 835.269 M | 846.266 M | 803.411 M | 778.121 M | 778.430 M | 952.692 M | 884.255 M | |
| Total liabilities | 108.984 M | 112.571 M | 118.770 M | 119.828 M | 99.245 M | 109.420 M | 283.896 M | 272.068 M | |
| Total current liabilities | 75.041 M | 90.032 M | 63.844 M | 65.056 M | 44.630 M | 53.041 M | 84.709 M | 79.402 M | |
| Accounts Payable | 15.747 M | 14.618 M | 10.088 M | 15.341 M | 14.097 M | 14.967 M | 13.914 M | 16.011 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 125.183 M | 113.367 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 6.332 M | 7.951 M | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 14.642 M | 12.489 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 125.183 M | 113.367 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 337.000 K | 0.000 | |
| Total Shareholder equity | 742.341 M | 722.698 M | 727.496 M | 683.583 M | 678.876 M | 669.010 M | 668.796 M | 612.187 M | |
| Common stock | 59.567 M | 59.717 M | 59.918 M | 59.772 M | 59.808 M | 60.622 M | 61.812 M | 61.212 M | |
| Retained earnings | -293.485 M | -326.244 M | -338.285 M | -399.048 M | -421.002 M | -445.271 M | -464.372 M | -532.405 M |